HF
CLBT icon

HRT Financial’s Cellebrite CLBT Stock Holding History

HRT Financial’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Buy
763,503
+265,960
+53% +$3.51M 0.02% 724
2026
Q1 		$6.86M Buy
497,543
+157,634
+46% +$2.38M 0.02% 811
2025
Q4 		$6.13M Buy
339,909
+115,045
+51% +$2.07M 0.02% 684
2025
Q3 		$4.17M Buy
224,864
+7,504
+3% +$118K 0.02% 761
2025
Q2 		$3.48M Buy
217,360
+102,520
+89% +$1.83M 0.02% 690
2025
Q1 		$2.23M Sell
114,840
-78,384
-41% -$1.65M 0.01% 767
2024
Q4 		$4.26M Sell
193,224
-54,372
-22% -$1.05M 0.02% 444
2024
Q3 		$4.17M Sell
247,596
-70,358
-22% -$1.04M 0.02% 553
2024
Q2 		$3.8M Buy
317,954
+22,231
+8% +$248K 0.02% 483
2024
Q1 		$3.28M Buy
295,723
+110,813
+60% +$1.13M 0.02% 390
2023
Q4 		$1.6M Buy
184,910
+116,028
+168% +$902K 0.01% 760
2023
Q3 		$526K Buy
+68,882
New +$517K 0.01% 1382

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

HRT Financial's CLBT Position: Q2 2026 in Review

HRT Financial increased its Cellebrite (CLBT) stake by 53% in Q2 2026, buying an estimated $3.51M and bringing the position to 763,503 shares worth $11.1M. The position accounts for 0.02% of the portfolio, ranked #724.

HRT Financial first reported a position in CLBT in Q3 2023 and has held it in 12 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • HRT Financial held 763,503 shares of Cellebrite worth $11.1M as of Q2 2026.
  • HRT Financial bought 265,960 Cellebrite shares in Q2 2026, an estimated $3.51M.
  • Cellebrite made up 0.02% of HRT Financial's portfolio in Q2 2026, its #724 holding.
  • HRT Financial first reported a position in Cellebrite in Q3 2023 and has held it in 12 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.